Implant Biomaterials Market

During the forecast period, the implant biomaterials market will grow at a rapid pace.

The global implant biomaterials market is steadily expanding, with a value of $34.8 billion in 2017 and a projected value of $64.0 billion by 2026. The market is growing due to the increasing global adoption of orthopedic implants, dental and cardiovascular procedures, the use of advanced biomaterials, and the preference for minimally invasive surgeries. Furthermore, rising medical tourism in developing nations, growing healthcare expenditure, swift approval of new advanced biomaterials, and growing demand for customized implants in the dental segment are also fueling the overall implant biomaterials market. New technological developments in CAD/CAM systems, rapid product commercialization, and encouraging public and government initiatives in the prosthetics industry across various countries in Asia Pacific and Europe will further assist in the overall market growth.

Other developments influencing the overall growth include innovation in computer-assisted implant dentistry (the cloud), usage of polymeric biomaterials, and novel formulations in polycarbonate urethanes and silicon. Increasing research and development on nanostructure, biomaterial surface, and coating, improvement in the standardization of the properties of biomaterials, and enhancement in bio-functionalization for future infection prevention are gaining traction in the global market. However, product recalls (medical implants), future risk of foreign body-related infections (FBRIs), implant failures, and post-surgery infections are factors restraining the overall market growth during the forecast period.

Market Synopsis

The composite material type segment is expected to register higher growth by the end of 2026.

The global sales of implant biomaterials for medical devices will experience a progressive impact from increasing technological interventions in the orthopedic and dental industries. The availability of a wide range of products in the global market incorporating bioresorbable polymer technology in stents, natural or synthetic polymers, metal or metal alloys such as titanium and zirconia, and bioactive ceramics showed significant growth during the forecast period. Additionally, the widespread use of bone graft biomaterials and current progress in synthetic graft biomaterials have led to the discovery of the further expansion of ceramic materials, bioactive glass, and porous titanium particles. The increasing demand for customized implants globally in the orthopedic and dental segments is going to spur further revenue growth during the forecast period. Increased applications of advanced biomaterials for joint replacements, modular tumor implants, and spine implants in the orthopedic segment are also generating a significant revenue share in the market.

Increasing applications for orthopedic and dental biomaterials will gain maximum share during the forecast period.

Increasing implant procedures in the cardiovascular, dental, and orthopedic segments, along with high-precision digital mapping technologies, are creating traction in the global market. Utilization of 3D printing technology, consistent new product launches, and usage of implant biomaterials in ophthalmology and drug delivery in developed nations are further going to spur revenue growth during the forecast period. In the dental segment, advancement in new biomaterials such as rooted, zirconia, and surface-modified titanium implants is also showing significant market growth.

Additionally, increased applications in cardiovascular (homograft valves, porcine and bovine valves), implant dentistry, reconstructive surgeries, and bone tissue engineering are also generating a significant revenue share in the market. Overall advancements in medical device components, regenerative medicine, tissue engineering, and collagen and tissue biomaterials applications are assisting the market’s overall growth.

A greater prevalence of dental and bone infections and the presence of established players hold North America in a dominant position.

North America contributes the maximum revenue share in the overall implant biomaterials market, which is attributed to increasing orthopedic implant procedures along with the aging population and higher adoption of branded biomaterials. According to an American Dental Association study, overall national dental expenditures in the United States increased from US$ 114 billion in 2014 to around US$ 117 billion in 2015. The high prevalence of oral and dental infection improved care and growing expenditure on oral care, new technology assessment in biomaterials, and increasing awareness and demand for aesthetic restorations in cosmetic dentistry in North America are all factors boosting overall industry growth.

Increasing demand for biomaterials for oral surgery, along with bone graft and membrane materials (bovine, allogeneic, and synthetic bone-graft materials), in developing nations is generating maximum revenue share in the dental industry. However, in the lower-income nations of Africa, Asia, and Latin America, the availability of cardiovascular, orthopedic, and dental treatment is inadequate. Lack of specialized healthcare professionals, less or no expansion of branded products, less awareness, and the high cost of advanced biomaterials, along with no reimbursement, are a few factors restraining the overall growth of the market.

The dominance of multinational manufacturers with strong product portfolios in the developed regions

Major players in the implant biomaterials market are Evonik Industries AG, Celanese Corp., Royal DSM, Invibio, Inc., DuPont, AdvanSource Biomaterials Corp., Collagen Matrix, Inc., Invibio Ltd., Collagen Solutions Plc., Keystone Dental, Inc., Surgical, SBM France, Zimmer Biomet, and others. Topmost manufacturers are executing growth strategies with technology assessments in advanced biomaterials, partnerships with dental hospitals and medical technology companies, and launching new implants with top-quality materials, especially in the orthopedic and dental segments. For instance, in September 2018, Henry Schein, Inc. declared three investments that would enhance the growth of the company. Henry Schein acquired Intra-Lock (a provider of dental restoration solutions, including proprietary surfaces, connections, biomaterials, and small-diameter implant technologies) and Medentis Medical (a dental implant manufacturer) to further strengthen its position in Europe. In June 2018, Keystone Dental, Inc. signed a definitive agreement to be acquired by Accelmed (a U.S. and Israel-based investment firm majorly dedicated to value creation for medical device companies and technologies).

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

The current report also includes qualitative and quantitative market valuation factors such as key market drivers, market trends, restraints, and opportunities to provide a better understanding of the implant biomaterials market as a whole. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths.

Key questions are answered in this report.

• What are the current market trends and dynamics in the implant biomaterials market, and what are the valuable opportunities for emerging players?
• What is the market positioning of the major market players?
• Which segment accounts for the fastest CAGR during the forecast period?
• Which application holds a larger market share and why?
• What is the impact of the high cost of implants and surgery on the global market?
• Are low- and middle-income economies investing in the implant biomaterials market?
• What are the market trends and dynamics in emerging markets such as Japan, Latin America, the Middle East, and Africa?

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global IB Market Portraiture
2.2. Global IB Market, By Material Type, 2017 (US$ Bn)
2.3. Global IB Market, By Application, 2017 (US$ Bn)
2.4. Global IB Market Share, by Geography, 2017 vs 2026 (Value %)

Chapter 3. Global Implant Biomaterials (IB) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Implant Biomaterial Technologies: Future Trends
3.3. Current Scenario: Partnership Strategies, Mergers & New Product Launches
3.4. Drivers
3.5. Challenges
3.6. Opportunities
3.7. Attractive Investment Proposition, by Geography, 2017
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Implant Biomaterials (IB) Market, by Material Type, 2016 – 2026 (US$ Bn)
4.1. Overview
4.2. Metal & Alloy Biomaterials
4.3. Polymer Biomaterials
4.4. Composite Biomaterials
4.5. Natural Biomaterials

Chapter 5. Global Implant Biomaterials (IB) Market, by Application, 2016 – 2026 (US$ Bn)
5.1. Overview
5.2. Orthopedics
5.3. Dental
5.4. Ophthalmic
5.5. Cardiovascular
5.6. Others (Soft Tissue Repair, Drug Delivery Systems, etc.)

Chapter 6. Global Implant Biomaterials (IB) Market, by Geography, 2016 – 2026 (US$ Bn)
6.1. Overview
6.2. North America IB Market Analysis, 2016 – 2026
6.2.1. North America IB Market, By Material Type, 2016 – 2026 (US$ Bn)
6.2.2. North America IB Market, By Application, 2016 – 2026 (US$ Bn)
6.2.3. North America IB Market, by Country, 2016 – 2026 (US$ Bn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe IB Market Analysis, 2016 – 2026
6.3.1. Europe IB Market, By Material Type, 2016 – 2026 (US$ Bn)
6.3.2. Europe IB Market, By Application, 2016 – 2026 (US$ Bn)
6.3.3. Europe IB Market, by Country, 2016 – 2026 (US$ Bn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific IB Market Analysis, 2016 – 2026
6.4.1. Asia Pacific IB Market, By Material Type, 2016 – 2026 (US$ Bn)
6.4.2. Asia Pacific IB Market, By Application, 2016 – 2026 (US$ Bn)
6.4.3. Asia Pacific IB Market, by Country, 2016 – 2026 (US$ Bn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America IB Market Analysis, 2016 – 2026
6.5.1. Latin America IB Market, By Material Type, 2016 – 2026 (US$ Bn)
6.5.2. Latin America IB Market, By Application, 2016 – 2026 (US$ Bn)
6.5.3. Latin America IB Market, by Country, 2016 – 2026 (US$ Bn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) IB Market Analysis, 2016 – 2026
6.6.1. MEA IB Market, by Material Type, 2016 – 2026 (US$ Bn)
6.6.2. MEA IB Market, by Application, 2016 – 2026 (US$ Bn)
6.6.3. MEA IB Market, by Region, 2016 – 2026 (US$ Bn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Evonik Industries AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Celanese Corp.
7.3. Royal DSM and Invibio, Inc.
7.4. DuPont
7.5. AdvanSource Biomaterials Corp.
7.6. Collagen Matrix, Inc.
7.7. Invibio Ltd.
7.8. Collagen Solutions Plc
7.9. Keystone Dental, Inc.
7.10. Surgival
7.11. SBM France
7.12. Zimmer Biomet

List of Figures

FIG. 1 Global Implant Biomaterials (IB) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global IB Market Segmentation
FIG. 4 Global IB Market, by Material Type, 2017 (US$ Bn)
FIG. 5 Global IB Market, by Application, 2017 (US$ Bn)
FIG. 6 Global IB Market, by Geography, 2017 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key Implant Biomaterials Manufacturers, 2017
FIG. 9 Global Metal & Alloy Implant Biomaterials Materials Market, 2016–2026 (US$ Bn)
FIG. 10 Global Polymer Implant Biomaterials Materials Market, 2016–2026 (US$ Bn)
FIG. 11 Global Composite Implant Biomaterials Materials Market, 2016–2026 (US$ Bn)
FIG. 12 Global Natural IB Market, 2016–2026 (US$ Bn)
FIG. 13 Global IB Market in Orthopedic Application, 2016–2026 (US$ Bn)
FIG. 14 Global IB Market in Dental Application, 2016–2026 (US$ Bn)
FIG. 15 Global IB Market in Ophthalmic Application, 2016–2026 (US$ Bn)
FIG. 16 Global IB Market in Cardiovascular Application, 2016–2026 (US$ Bn)
FIG. 17 Global IB Market in Other Applications, 2016–2026 (US$ Bn)
FIG. 18 U.S. IB Market, 2016–2026 (US$ Bn)
FIG. 19 Canada IB Market, 2016–2026 (US$ Bn)
FIG. 20 U.K. IB Market, 2016–2026 (US$ Bn)
FIG. 21 Germany IB Market, 2016–2026 (US$ Bn)
FIG. 22 Rest of Europe IB Market, 2016–2026 (US$ Bn)
FIG. 23 Japan IB Market, 2016–2026 (US$ Bn)
FIG. 24 China IB Market, 2016–2026 (US$ Bn)
FIG. 25 Rest of Asia Pacific IB Market, 2016–2026 (US$ Bn)
FIG. 26 Brazil IB Market, 2016–2026 (US$ Bn)
FIG. 27 Mexico IB Market, 2016–2026 (US$ Bn)
FIG. 28 Rest of Latin America IB Market, 2016–2026 (US$ Bn)
FIG. 29 GCC IB Market, 2016–2026 (US$ Bn)
FIG. 30 Rest of Middle East & Africa IB Market, 2016–2026 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Implant Biomaterials (IB) Market
TABLE 2 Global IB Market, by Material Type, 2016–2026 (US$ Bn)
TABLE 3 Global IB Market, by Application, 2016–2026 (US$ Bn)
TABLE 4 Global IB Market, by Geography, 2016–2026 (US$ Bn)
TABLE 5 North America IB Market, by Material Type, 2016–2026 (US$ Bn)
TABLE 6 North America IB Market, by Application, 2016–2026 (US$ Bn)
TABLE 7 North America IB Market, by Country, 2016–2026 (US$ Bn)
TABLE 8 Europe IB Market, by Material Type, 2016–2026 (US$ Bn)
TABLE 9 Europe IB Market, by Application, 2016–2026 (US$ Bn)
TABLE 10 Europe IB Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 11 Latin America IB Market, by Material Type, 2016–2026 (US$ Bn)
TABLE 12 Latin America IB Market, by Application, 2016–2026 (US$ Bn)
TABLE 13 Latin America IB Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 14 Asia Pacific IB Market, by Material Type, 2016–2026 (US$ Bn)
TABLE 15 Asia Pacific IB Market, by Application, 2016–2026 (US$ Bn)
TABLE 16 Asia Pacific IB Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 17 Middle East & Africa IB Market, by Material Type, 2016–2026 (US$ Bn)
TABLE 18 Middle East & Africa IB Market, by Application, 2016–2026 (US$ Bn)
TABLE 19 Middle East & Africa IB Market, by Region, 2016–2026 (US$ Bn)
TABLE 20 Evonik Industries AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Celanese Corp.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 DuPont: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 AdvanSource Biomaterials Corp.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Collagen Matrix, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments0029
TABLE 25 Invibio Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Collagen Solutions Plc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Keystone Dental, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Surgival: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 SBM France: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Zimmer Biomet: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)